Search

everythinglearnresearchcommunity

for

Search:↓

ATIR101 improves survival in stem cell transplant patients; Australian stem cell treatment decisions are influenced by regulation changes.

Pantethine may boost the immune system's ability to fight sarcoma.

Fetal skin has unique immune cells different from adult skin.

Understanding the immune-related causes of Alopecia Areata has led to potential treatments like JAK inhibitors.

Dental pulp stem cells might not reliably become neurons.

Most pediatric cancer patients in the study developed skin problems, often due to their cancer treatment.

Certain immune markers may predict chemotherapy response in mesothelioma, and nivolumab is a tolerable and effective treatment for advanced non-small cell lung cancer.

Alopecia areata and vitiligo share immune system dysfunction but differ in specific immune responses and affected areas.

Fibroblasts are crucial for tissue repair and inflammation, and understanding them can help treat fibrotic diseases.

Hair follicles are normally protected from the immune system, but when this protection fails, it can cause hair loss in alopecia areata.

Vitamin A affects hair loss and immune response in alopecia areata.

Melanoma's complexity requires personalized treatments due to key genetic mutations and tumor-initiating cells.

Different parts of the body have unique immune characteristics in their skin.

Non-coding RNAs are important for hair growth and could lead to new hair loss treatments, but more research is needed.

Foxp3+ Regulatory T Cells are important for immunity and tolerance, affect hair growth and wound healing, and their dysfunction can contribute to obesity-related diseases and other health issues.

Vitamin B5 and coenzyme A may help regulate the immune system and could improve treatments for chronic diseases and cancer.

Exosomes could be key in treating skin conditions and healing wounds.

Alopecia areata needs more recognition and better treatment access in Latin America to improve patient care and outcomes.

The symposium highlighted the importance of genetics in understanding and treating complex skin diseases.

Hair follicle cells help protect against immune attacks by regulating T-cell activity.

Immunotherapy for cancer caused a patient to develop a condition affecting hormone production, requiring ongoing hormone replacement therapy.

Higher PD-1 levels are linked to fewer immune cells in hair follicles in alopecia areata.

Higher levels of PD-L1 are linked to more severe hair loss in people with Alopecia Areata.

The conclusion is that Treg-targeted therapies have potential, but more knowledge of Treg biology is needed for effective treatments, including for cancer.

Cancer patients treated with immune checkpoint inhibitors may develop alopecia, but some hair regrowth is possible with treatment.

A cancer patient's hair became permanently curly after treatment with nivolumab.

Certain proteins can either protect against or increase the risk of hypertrophic scars.

In 2019, dermatology and venereology improved skin cancer imaging, advanced in treating skin conditions like psoriasis, and explored the skin microbiome's role in diseases.

Spanish experts provided guidelines for treating skin side effects in cancer patients on new therapies, stressing early action and teamwork.

Scalp cooling is the most effective FDA-approved method to prevent chemotherapy-induced hair loss, but more research is needed for other treatments.